(Q50262134)

28 February 2018

title

Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases. (English)

1 reference

28 February 2018

author name string

Kamel Masmoudi

1

1 reference

28 February 2018

Henri Masson

2

1 reference

28 February 2018

Valérie Gras

3

1 reference

28 February 2018

Michel Andréjak

4

1 reference

28 February 2018

publication date

2 November 2011

1 reference

28 February 2018

Fundamental and Clinical Pharmacology

published in

1 reference

28 February 2018

volume

26

1 reference

28 February 2018

issue

2

1 reference

28 February 2018

page(s)

198-203

1 reference

28 February 2018

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

Trimetazidine induces parkinsonism, gait disorders and tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

Trimetazidine: a new cause for drug-induced parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

Trimetazidine-induced encephalopathy with choreiform disorders: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

Drug induced parkinsonism: a common cause of parkinsonism in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2011.01008.X

10.1111/J.1472-8206.2011.01008.X

21 January 2018

Identifiers

DOI

1 reference

28 February 2018

1 reference

28 February 2018